Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Incannex Healthcare (IXHL) EBITDA Margin (2024 - 2025)

Historic EBITDA Margin for Incannex Healthcare (IXHL) over the last 2 years, with Q3 2025 value amounting to 124000.0%.

  • Incannex Healthcare's EBITDA Margin fell 1171081100.0% to 124000.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 281288.24%, marking a year-over-year decrease of 2510179700.0%. This contributed to the annual value of 54302.33% for FY2025, which is 1001643400.0% up from last year.
  • As of Q3 2025, Incannex Healthcare's EBITDA Margin stood at 124000.0%, which was down 1171081100.0% from 52566.67% recorded in Q4 2024.
  • Incannex Healthcare's 5-year EBITDA Margin high stood at 6891.89% for Q3 2024, and its period low was 124000.0% during Q3 2025.